patent expiration

Annual Drug Patent Expirations for AFINITOR Afinitor is a drug marketed by Novartis and Novartis Pharm and is included in two NDAs. It is available from one supplier. There are…
The post New patent expiration for Novartis drug AFINITOR appeared first o…

AFINITOR (everolimus) Novartis Patent: 8,778,962 Expiration: Aug 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pa…

Annual Drug Patent Expirations for KINEVAC Kinevac is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent expiration for Bracco drug KINEVAC appeared first on Drug…

IXEMPRA KIT (ixabepilone) R-pharm us llc Patent: RE41393 Expiration: Aug 8, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for the Wee…

Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent expiration for Viiv Hlthcare drug JULUCA appeared first on Dr…

Annual Drug Patent Expirations for EDURANT Edurant is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Janssen Prods drug EDURANT appeared first o…

Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Gilead Sciences drug ODEFSEY appeared first …

Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are nine…
The post New patent expiration for Gilead Sciences drug COMPLERA appeared firs…

Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for R-pharm Us drug IXEMPRA KIT appeared first on D…

Annual Drug Patent Expirations for DUAKLIR+PRESSAIR Duaklir Pressair is a drug marketed by Covis and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent expiration for COVIS drug DUAKLIR PRESSAIR appe…